EMMAC Life Sciences Ltd — Form D
EMMAC Life Sciences Ltd of LONDON, X0, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-15. The offering totals $9.4M, of which $9.4M was reported sold. Industry: Other.
Offering
- Filed: 2021-01-15
- Form: D
- Accession: 0001062993-21-000387
- Industry: Other
- Exemptions: 06b
- Total offering: $9.4M
- Amount sold: $9.4M
- Minimum investment: $67K
- Investors: 10
- Date of first sale: 2020-11-26
- Revenue range: Decline to Disclose
- SEC file number: 021-386429
Issuer
- Name: EMMAC Life Sciences Ltd
- CIK: 0001789520
- Entity type: Corporation
- Jurisdiction: UNITED KINGDOM
- Incorporated: 2018
- Address: C/O HILL DICKINSON LLP, LONDON, X0, EC2A2EW
- Phone: 04407872464792
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Lorne Abony | Director | Austin, TX |
| Antonio Costanzo | Director | Toronto, A6 |
| Antonio Costanzo | Executive Officer | Toronto, A6 |
| Thomas Ellen | Director | London, X0 |
| Thomas Ellen | Executive Officer | London, X0 |
| Thomas Rooke | Director | London, X0 |
| Thomas Rooke | Executive Officer | London, X0 |
| Edward McDermott | Director | London, X0 |
| Edward McDermott | Executive Officer | London, X0 |
| Barbara Pacchetti | Director | London, X0 |
| Barbara Pacchetti | Executive Officer | London, X0 |
| Orr Yarkoni | Director | London, X0 |
Other filings by this issuer (4)
More